Skip to main content

CJC-1295 (no DAC) vs GHRP-2

Both CJC-1295 (no DAC) and GHRP-2 are used for growth-hormone and anti-aging. Here's how their evidence, dosing, and regulatory status actually compare.

CJC-1295 (no DAC)

Evidence B

Modified Growth Hormone Releasing Factor 1-29

A growth hormone releasing hormone (GHRH) analog most commonly stacked with Ipamorelin to stimulate natural GH pulsatile release without disrupting the hypothalamic axis.

View full CJC-1295 (no DAC) profile →

GHRP-2

Evidence B

Growth Hormone Releasing Peptide 2

A potent synthetic ghrelin-mimetic GH secretagogue. Drives strong GH spikes but raises cortisol and prolactin more than newer alternatives like Ipamorelin.

View full GHRP-2 profile →

Side-by-Side

AttributeCJC-1295 (no DAC)GHRP-2
Evidence GradeBB
FDA StatusNot FDA-approved — Category 1 (compounding allowed)Not FDA-approved — research compound; previously studied as growth hormone deficiency diagnostic
Typical Dose100–300 mcg before bed (subcutaneous)100–300 mcg, 1–3 times daily (subcutaneous)
Clinics Indexed15686
Categoriesgrowth-hormone, anti-aging, recoverygrowth-hormone, anti-aging

Key reported benefits — CJC-1295 (no DAC)

  • Growth hormone release
  • Fat loss
  • Improved sleep
  • Muscle recovery

Key reported benefits — GHRP-2

  • Strong GH release
  • Appetite stimulation
  • Muscle recovery

Educational use only

This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.

← Back to all comparisons